NovoLog Mix 70/30 (INSULIN ASPART)
NovoLog Mix 70/30 (INSULIN ASPART) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: NovoLog Mix 70/30; Generic name: INSULIN ASPART; Drug class: Insulin Analog [EPC].
| Brand name | NovoLog Mix 70/30 |
|---|---|
| Generic name | INSULIN ASPART |
| Drug class | Insulin Analog [EPC] |
| Manufacturer | A-S Medication Solutions |
| Used for | 1 INDICATIONS AND USAGE NOVOLOG MIX 70/30 is a mixture of insulin aspart protamine and insulin aspart indicated to improve glycemic control in adult patients with diabetes mellitus. Limitations of Use: • NOVOLOG MIX 70/30 is not recommended for the treatment of diabetic ketoacidosis. • The proportions of rapid-acting and long-acting insulins in NOVOLOG MIX 70/30 are fixed and do not allow for basal versus prandial dose adjustments. NOVOLOG MIX 70/30 is a mixture of insulin aspart protamine, an intermediate-acting human insulin analog, and insulin aspart, a rapid-acting human insulin analog, indicated to improve glycemic control in adult patients with diabetes mellitus. Limitations of Use: • |
| Dosage | 2 DOSAGE AND ADMINISTRATION • Inspect visually before use. Appearance should be uniformly white and cloudy. Do not use it if it looks clear or if it contains solid particles ( 2.1 ). • NOVOLOG MIX 70/30 must be resuspended immediately before use. Resuspension is easier when the insulin has reached room temperature ( 2.1 ). • Inject NOVOLOG MIX 70/30 subcutaneously in the abdominal region, buttocks, thigh, or upper arm (2.1). • Administer the dose within 15 minutes before meal initiation. For pat |
| Active ingredient(s) | INSULIN ASPART |
| Route | SUBCUTANEOUS |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=19888a44-b330-462a-864d-338c5893dd63 |